Table 5.
Results of Subgroup Analysis on Impact of FASDs on Hospitalization, stratified by Hospitalization Cause.
FASD (n = 3,103) | General Population (n = 15,515) | None | Hospitalization | |||||||
---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p-value | ||||||||
n | % | n | % | Lower | Upper | |||||
Hospitalization Causes | ||||||||||
All-Causes | 853 | 27.5 | 1,673 | 10.8 | 1.00 | 1.25 | 1.05 | – | 1.49 | 0.0114 |
Nervous | 450 | 14.5 | 18 | 0.1 | 1.00 | 51.78 | 29.09 | – | 92.17 | < .0001 |
Mental | 179 | 5.8 | 32 | 0.1 | 1.00 | 7.87 | 4.34 | – | 14.26 | < .0001 |
Circulatory | 59 | 1.9 | 112 | 0.5 | 1.00 | 1.18 | 0.67 | – | 2.09 | 0.5748 |
Abnormal | 32 | 1.0 | 26 | 0.1 | 1.00 | 1.97 | 0.72 | – | 5.38 | 0.1861 |
Musculoskeletal | 31 | 1.0 | 138 | 0.6 | 1.00 | 0.33 | 0.16 | – | 0.68 | 0.0027 |
Digestive | 23 | 0.7 | 135 | 0.6 | 1.00 | 0.30 | 0.14 | – | 0.63 | 0.0014 |
Neoplasm | 22 | 0.7 | 19 | 0.1 | 1.00 | 0.94 | 0.27 | – | 3.23 | 0.9230 |
Eye and Ear | 17 | 0.5 | 158 | 0.7 | 1.00 | 0.41 | 0.19 | – | 0.88 | 0.0227 |
Endocrine | 11 | 0.4 | 35 | 0.2 | 1.00 | 0.41 | 0.11 | – | 1.55 | 0.1878 |
Other* | 29 | 0.9 | 1,000 | .4 | 1.00 | 0.08 | 0.05 | – | 0.14 | < .0001 |
*Infectious, genitourinary, respiratory, external, perinatal, congenital, respiratory, skin.